MONTANOVA CAPITAL, LLC

NEW YORK, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$3.63B2026 Q3+ $671.5M options (notional, not included)
Positions90
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.53.5%

MONTANOVA CAPITAL, LLC reported 90 positions worth $3.63B as of September 30, 2026 (13F filed November 16, 2026). Largest holding: QQQ (11.2%). Biggest move: reduce SPY ($533.8M).

10 / 90 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 QQQPutInvesco QQQ Tr$480.9M notional11.19%650,000———
▸ 2 MANEVeradermics$450.9M10.49%3,718,970——+5.6%
▸ 3 ARQTArcutis Biotherapeutics$324.3M7.54%12,269,000——+2.7%
▸ 4 SPYPutSPDR S&P 500$190.7M notional4.44%250,000———
▸ 5 NVDANVIDIA$160.3M3.73%701,901——-31.6%
▸ 6 AVBPArriVent BioPharma$149.1M3.47%4,925,531——-57.0%
▸ 7 PVLAPalvella Therapeutics$144.1M3.35%1,044,898——+4.8%
▸ 8 BHVNBiohaven$137.3M3.20%10,286,937———
▸ 9 TSMTaiwan Semiconductor$133.6M3.11%292,967——-18.1%
▸ 10 METAMeta Platforms$127.4M2.96%175,640——-13.6%

Pro Feature

The remaining 80 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does MONTANOVA CAPITAL, LLC hold as of Q3 2026?

MONTANOVA CAPITAL, LLC reported 90 positions worth $3.63B in its Q3 2026 13F filing. Largest positions: QQQ (11.2%), MANE (10.5%), ARQT (7.5%), SPY (4.4%) and NVDA (3.7%).

What did MONTANOVA CAPITAL, LLC buy in Q3 2026?

New positions: QQQ, CCL, BURL, RCL and QURE (12 in all). Added to: SPCX, REPL, MLM, MLYS and CBRS (17 in all).

What did MONTANOVA CAPITAL, LLC sell in Q3 2026?

Reduced: SPY, HD, COF, MANE and HUT (31 in all). Sold out entirely: AMD, RCUS, CAPR, FERG and CRNXGBP (18 in all).

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.